Vanguard Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$148M Buy
1,879,009
+85,945
+5% +$5.97M ﹤0.01% 1291
2026
Q2
$113M Buy
1,793,064
+32,523
+2% +$2.08M ﹤0.01% 1502
2026
Q1
$124M Buy
+1,760,541
New +$123M ﹤0.01% 1358

Other funds holding TARS

Vanguard Capital Management's TARS Position: Q3 2026 in Review

Vanguard Capital Management increased its Tarsus Pharmaceuticals (TARS) stake by 4.8% in Q3 2026, buying an estimated $5.97M and bringing the position to 1,879,009 shares worth $148M. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Vanguard Capital Management first reported a position in TARS in Q1 2026 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Vanguard Capital Management held 1,879,009 shares of Tarsus Pharmaceuticals worth $148M as of Q3 2026.
  • Vanguard Capital Management bought 85,945 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $5.97M.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1291 holding.
  • Vanguard Capital Management first reported a position in Tarsus Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.